Panobinostat
CAS 404950-80-7 2 FDA-DMF suppliersSmall Molecule
Overview
Panobinostat is a potent pan-deacetylase inhibitor with activity against multiple myeloma and other hematological malignancies. It is specifically designed to inhibit the enzymatic activity of histone deacetylases (HDACs), potentially resulting in cell cycle arrest and apoptosis of cancer cells.
Therapeutic areas
OncologyHematology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.